Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Pathological findings of gastric mucosa in patients with gastric remnant cancer.

Sasaki K, Fujiwara Y, Kishi K, Motoori M, Yano M, Ohigashi H, Ohue M, Noura S, Maruhashi S, Takahashi H, Gotoh K, Shingai T, Yamamoto T, Tomita Y, Ishikawa O.

Hepatogastroenterology. 2014 Jan-Feb;61(129):251-4.

PMID:
24895831
2.

Endoscopic submucosal dissection for early gastric cancer in the remnant stomach after gastrectomy.

Nonaka S, Oda I, Makazu M, Haruyama S, Abe S, Suzuki H, Yoshinaga S, Nakajima T, Kushima R, Saito Y.

Gastrointest Endosc. 2013 Jul;78(1):63-72. doi: 10.1016/j.gie.2013.02.006. Epub 2013 Apr 6.

PMID:
23566640
3.

Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy.

Komatsu S, Ichikawa D, Okamoto K, Ikoma D, Tsujiura M, Nishimura Y, Murayama Y, Shiozaki A, Ikoma H, Kuriu Y, Nakanishi M, Fujiwara H, Ochiai T, Kokuba Y, Otsuji E.

World J Gastroenterol. 2012 Jun 14;18(22):2832-6. doi: 10.3748/wjg.v18.i22.2832.

4.

Effect of H. pylori on COX-2 expression in gastric remnant after distal gastrectomy.

Fukuhara K, Osugi H, Takada N, Takemura M, Lee S, Morimura K, Taguchi S, Kaneko M, Tanaka Y, Fujiwara Y, Nishizawa S, Fukushima S, Kinoshita H.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1515-8.

PMID:
15362790
5.

[Clinicopathological characteristics and prognosis of remnant stomach cancer--report of 45 cases].

Xu DK, Zhao P, Wang CF, Shao YF, Lin HW, Tian YT.

Zhonghua Zhong Liu Za Zhi. 2006 Nov;28(11):852-4. Chinese.

PMID:
17416009
6.

Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.

Onoda N, Katsuragi K, Sawada T, Maeda K, Mino A, Ohira M, Ishikawa T, Wakasa K, Hirakawa K.

J Exp Clin Cancer Res. 2005 Dec;24(4):515-21.

PMID:
16471313
7.

Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach.

Kato S, Naito Z, Matsuda N, Onodera H, Sakurazawa N, Yamashita N, Kanazawa Y, Fujita I, Makino H, Uchida E.

J Nippon Med Sch. 2011;78(4):224-34.

8.

Reconstructive procedure after distal gastrectomy to prevent remnant gastritis.

Osugi H, Fukuhara K, Takada N, Takemura M, Kinoshita H.

Hepatogastroenterology. 2004 Jul-Aug;51(58):1215-8.

PMID:
15239282
9.

Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography.

Nakase Y, Sakakura C, Miyagawa K, Kin S, Fukuda K, Yanagisawa A, Koide K, Morofuji N, Hosokawa Y, Shimomura K, Katsura K, Hagiwara A, Yamagishi H, Ito K, Ito Y.

Br J Cancer. 2005 Feb 14;92(3):562-9.

10.

Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer.

Nomura E, Lee SW, Bouras G, Tokuhara T, Hayashi M, Hiramatsu M, Okuda J, Tanigawa N.

Gastric Cancer. 2011 Aug;14(3):279-84. doi: 10.1007/s10120-011-0046-0. Epub 2011 Apr 26.

PMID:
21519869
11.

Early and late gastric cancer arising in the remnant stomach after distal gastrectomy.

Takeno S, Noguchi T, Kimura Y, Fujiwara S, Kubo N, Kawahara K.

Eur J Surg Oncol. 2006 Dec;32(10):1191-4. Epub 2006 Jun 21.

PMID:
16797159
12.

Different carcinogenesis in the gastric remnant after gastrectomy for gastric cancer.

Kaminishi M, Shimizu N, Yamaguchi H, Hashimoto M, Sakai S, Oohara T.

Cancer. 1996 Apr 15;77(8 Suppl):1646-53.

13.

Expression of 8-hydroxydeoxyguanosine in the gastric remnant after distal gastrectomy.

Fukuhara K, Osugi H, Takemura M, Lee S, Morimura K, Nishikawa T, Iwasaki H, Fukushima S, Suehiro S.

Hepatogastroenterology. 2008 Mar-Apr;55(82-83):508-11.

PMID:
18613397
14.

bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.

Clarke MR, Safatle-Ribeiro AV, Ribeiro U, Sakai P, Reynolds JC.

Mod Pathol. 1997 Oct;10(10):1021-7.

PMID:
9346182
15.

[Surgical treatment of gastric remnant-stump cancer].

Zhang Y, Tokunaga A, Masuda G, Okuda T, Kiyama T, Yoshiyuki T, Kato S, Matsukura N, Tajiri T, Onda M.

J Nippon Med Sch. 2002 Oct;69(5):489-93. Japanese.

16.

Usefulness of pyloric reconstruction without compromising curative resection in gastric cancer treatment.

Hoya Y, Taki T, Tanaka Y, Hoshino M, Okamoto T, Kashiwagi H, Yanaga K.

J Gastrointest Surg. 2012 Jun;16(6):1102-6. doi: 10.1007/s11605-012-1850-5. Epub 2012 Mar 6.

PMID:
22392089
17.

Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection.

Lee Y, Tokunaga A, Tajiri T, Masuda G, Okuda T, Fujita I, Kiyama T, Yoshiyuki T, Kato S, Matsukura N, Yamada N.

J Gastroenterol. 2004 Jun;39(6):520-6.

PMID:
15235868
18.

Lymph node dissection in surgical treatment for remnant stomach cancer.

Kunisaki C, Shimada H, Nomura M, Hosaka N, Akiyama H, Ookubo K, Moriwaki Y, Yamaoka H.

Hepatogastroenterology. 2002 Mar-Apr;49(44):580-4.

PMID:
11995502
19.

Flow cytometric analysis of the DNA content of tumor cells in cases of gastric cancer in the upper third of the stomach and in the remnant stomach.

Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N.

Oncology. 1995 Mar-Apr;52(2):116-22.

PMID:
7854770
20.

Early gastric cancer in the remnant stomach.

Takeda J, Toyonaga A, Koufuji K, Kodama I, Aoyagi K, Yano S, Ohta J, Shirozu K.

Hepatogastroenterology. 1998 Sep-Oct;45(23):1907-11.

PMID:
9840174

Supplemental Content

Support Center